How is Brexucabtagene Autoleucel dosed?
The dosage of Brexucabtagene Autoleucel is determined by a healthcare professional based on the patient's weight and specific condition. It is given as an intravenous infusion. The drug is available in a suspension form. It is important to follow the healthcare professional's instructions for dosing and treatment duration. Individual dosages may vary based on factors such as age, weight, medical history, and response to treatment. Consult with a healthcare professional for personalized advice and dosing instructions.
What is the dosage form of Brexucabtagene Autoleucel?
Brexucabtagene Autoleucel is available in a suspension form.
How is Brexucabtagene Autoleucel administered?
Brexucabtagene Autoleucel is administered through an injection into a vein. It is typically given by a healthcare professional in a medical setting, such as a hospital or clinic. This medicine is available only under a restricted distribution program called the Yescarta闁告柨篓nd Tecartus闁 REMS (Risk Evaluation and Mitigation Strategy) Program.
What are common precautions when taking Brexucabtagene Autoleucel?
Common precautions when taking Brexucabtagene Autoleucel include:
- Inform your doctor about any allergies you have.
- Report any side effects to the FDA at 1-800-FDA-1088.
- Avoid live virus vaccinations for at least 6 weeks before starting treatment, during treatment, and until recovery following the last cycle of the medicine.
- Be cautious while driving or engaging in activities that require alertness or coordination, as the medicine may cause dizziness, confusion, seizures, or decreased alertness.
- Inform your doctor about any other medications you are taking, as interactions may occur.
- Undergo routine monitoring by your healthcare professional while using the medicine. Follow your doctor's instructions and discuss any concerns you may have regarding the usage of this medication.